{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:26:45Z","timestamp":1788805605647,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-024-01798-5","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T14:26:23Z","timestamp":1734531983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling"],"prefix":"10.1186","volume":"16","author":[{"given":"Machteld","family":"Baetens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Van Gaever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Deblaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andries","family":"De Koker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"Meuris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Callewaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Roelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Roets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Van Dorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dehaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Menten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"1798_CR1","doi-asserted-by":"publisher","first-page":"S9.e1","DOI":"10.1016\/j.ajog.2015.08.003","volume":"213","author":"CWG Redman","year":"2015","unstructured":"Redman CWG, Staff AC. Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity. Am J Obstet Gynecol. 2015;213:S9.e1-S9.e4.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-022-00413-2","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis E, et al. Pre-eclampsia. Nat Rev Dis Prim. 2023;9:1\u201322.","journal-title":"Nat Rev Dis Prim"},{"key":"1798_CR3","doi-asserted-by":"publisher","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019. https:\/\/doi.org\/10.1136\/bmj.l2381.","DOI":"10.1136\/bmj.l2381"},{"key":"1798_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.fertnstert.2017.08.035","volume":"108","author":"CK Sites","year":"2017","unstructured":"Sites CK, et al. Embryo cryopreservation and preeclampsia risk. Fertil Steril. 2017;108:784\u201390.","journal-title":"Fertil Steril"},{"key":"1798_CR5","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/1471-0528.15661","volume":"126","author":"S Santos","year":"2019","unstructured":"Santos S, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts. BJOG An Int J Obstet Gynaecol. 2019;126:984\u201395.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1798_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-46011-3","volume":"9","author":"J Mayrink","year":"2019","unstructured":"Mayrink J, et al. Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019;9:1\u20139.","journal-title":"Sci Rep"},{"key":"1798_CR7","doi-asserted-by":"publisher","first-page":"S867","DOI":"10.1016\/j.ajog.2021.11.019","volume":"226","author":"PY Robillard","year":"2022","unstructured":"Robillard PY, Dekker G, Scioscia M, Saito S. Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia. Am J Obstet Gynecol. 2022;226:S867\u201375.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369.","journal-title":"Pregnancy Hypertens"},{"key":"1798_CR9","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.bpobgyn.2024.102480","volume":"94","author":"JM Roberts","year":"2024","unstructured":"Roberts JM. Preeclampsia epidemiology(ies) and pathophysiology(ies) James. Best Pract Res Clin Obstet Gynaecol. 2024;94:102480.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1798_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/1471-0528.16683","volume":"128","author":"T Pittara","year":"2021","unstructured":"Pittara T, Vyrides A, Lamnisos D, Giannakou K. Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review. BJOG An Int J Obstet Gynaecol. 2021;128:1421\u201330.","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"1798_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.12802","volume":"145","author":"LC Poon","year":"2019","unstructured":"Poon LC, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention. Int J Gynecol Obstet. 2019;145:1\u201333.","journal-title":"Int J Gynecol Obstet"},{"issue":"544","key":"1798_CR12","first-page":"e1","volume":"209","author":"S Lisonkova","year":"2013","unstructured":"Lisonkova S, Joseph KS. Incidence of preeclampsia: Risk factors and outcomes associated with early-versus late-onset disease. Am J Obstet Gynecol. 2013;209(544):e1-544.e12.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR13","volume-title":"Preeclampsia\u2014basic, genomic, and clinical","author":"S Saito","year":"2018","unstructured":"Saito S. Preeclampsia\u2014basic, genomic, and clinical. Berlin: Springer; 2018."},{"key":"1798_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2010.12.002","volume":"1","author":"GJ Burton","year":"2011","unstructured":"Burton GJ, Yung HW. Endoplasmic reticulum stress in the pathogenesis of early-onset pre-eclampsia. Pregnancy Hypertens. 2011;1:72\u20138.","journal-title":"Pregnancy Hypertens"},{"key":"1798_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11906-022-01184-7","volume":"24","author":"XQ Hu","year":"2022","unstructured":"Hu XQ, Zhang L. Mitochondrial dysfunction in the pathogenesis of endothelial dysfunction. Curr Hypertens Rep. 2022;24:157\u201372.","journal-title":"Curr Hypertens Rep"},{"key":"1798_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15:275\u201389.","journal-title":"Nat Rev Nephrol"},{"key":"1798_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","journal-title":"N Engl J Med"},{"key":"1798_CR18","doi-asserted-by":"publisher","first-page":"103968","DOI":"10.1016\/j.jri.2023.103968","volume":"158","author":"P-Y Robillard","year":"2023","unstructured":"Robillard P-Y, et al. Preeclampsia in 2023: time for preventing early onset- and term preeclampsia: The paramount role of gestational weight gain. J Reprod Immunol. 2023;158:103968.","journal-title":"J Reprod Immunol"},{"key":"1798_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/uog.18899","volume":"50","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, et al. Early screening and prevention of preterm pre-eclampsia with aspirin: time for clinical implementation. Ultrasound Obstet Gynecol. 2017;50:551\u20136.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1798_CR20","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226:S1108\u201319.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR21","doi-asserted-by":"publisher","unstructured":"Rolnik DL, et al. Aspirin for evidence-based preeclampsia prevention trial: effects of aspirin on maternal serum pregnancy-associated plasma protein A and placental growth factor trajectories in pregnancy. Am J Obstet Gynecol. 2023. https:\/\/doi.org\/10.1016\/j.ajog.2023.12.031.","DOI":"10.1016\/j.ajog.2023.12.031"},{"key":"1798_CR22","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/1471-0528.14029","volume":"123","author":"ZTA Al-Rubaie","year":"2016","unstructured":"Al-Rubaie ZTA, Askie LM, Ray JG, Hudson HM, Lord SJ. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. BJOG Int J Obstet Gynaecol. 2016;123:1441\u201352.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1798_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/1471-0528.17320","volume":"131","author":"T Elawad","year":"2024","unstructured":"Elawad T, et al. Risk factors for pre-eclampsia in clinical practice guidelines: comparison with the evidence. BJOG Int J Obstet Gynaecol. 2024;131:46\u201362.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1798_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, et al. Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13\u201322.","journal-title":"N Engl J Med"},{"key":"1798_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","volume":"27","author":"S Verlohren","year":"2022","unstructured":"Verlohren S, et al. Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia. Pregnancy Hypertens. 2022;27:42\u201350.","journal-title":"Pregnancy Hypertens"},{"key":"1798_CR26","doi-asserted-by":"publisher","first-page":"S1048","DOI":"10.1016\/j.ajog.2020.09.046","volume":"226","author":"S Verlohren","year":"2022","unstructured":"Verlohren S, Dr\u00f6ge LA. The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. Am J Obstet Gynecol. 2022;226:S1048\u201358.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1515\/jpm-2022-0353","volume":"51","author":"DCS Melo","year":"2023","unstructured":"Melo DCS, et al. The role of the soluble fms-like tyrosine kinase-1\/placental growth factor (sFlt-1\/PIGF) - Ratio in clinical practice in obstetrics: diagnostic and prognostic value. J Perinat Med. 2023;51:896\u2013903.","journal-title":"J Perinat Med"},{"key":"1798_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0156013","volume":"11","author":"E Klein","year":"2016","unstructured":"Klein E, et al. Influence of the sFlt-1\/PlGF ratio on clinical decision-making in women with suspected preeclampsia. PLoS One. 2016;11:1\u201319.","journal-title":"PLoS One"},{"key":"1798_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.semperi.2014.03.005","volume":"38","author":"JM Roberts","year":"2014","unstructured":"Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol. 2014;38:139\u201345.","journal-title":"Semin Perinatol"},{"key":"1798_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.preghy.2010.12.001","volume":"1","author":"VD Winn","year":"2011","unstructured":"Winn VD, Gormley M, Fisher SJ. The impact of preeclampsia on gene expression at the maternal-fetal interface. Pregnancy Hypertens. 2011;1:100\u20138.","journal-title":"Pregnancy Hypertens"},{"key":"1798_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/HJH.0b013e328344a82c","volume":"29","author":"JH Kang","year":"2011","unstructured":"Kang JH, et al. Preeclampsia leads to dysregulation of various signaling pathways in placenta. J Hypertens. 2011;29:928\u201336.","journal-title":"J Hypertens"},{"key":"1798_CR32","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.placenta.2010.04.014","volume":"32","author":"T V\u00e1rkonyi","year":"2011","unstructured":"V\u00e1rkonyi T, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011;32:S21\u20139.","journal-title":"Placenta"},{"issue":"604","key":"1798_CR33","first-page":"e1","volume":"219","author":"SJ Benton","year":"2018","unstructured":"Benton SJ, Leavey K, Grynspan D, Cox BJ, Bainbridge SA. The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology. Am J Obstet Gynecol. 2018;219(604):e1-604.e25.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.116.07293","volume":"68","author":"K Leavey","year":"2016","unstructured":"Leavey K, et al. Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia. Hypertension. 2016;68:137\u201347.","journal-title":"Hypertension"},{"key":"1798_CR35","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1073\/pnas.1215145110","volume":"110","author":"DI Schroeder","year":"2013","unstructured":"Schroeder DI, et al. The human placenta methylome. Proc Natl Acad Sci U S A. 2013;110:6037\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1798_CR36","doi-asserted-by":"publisher","unstructured":"Novakovic B, et al. Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental\/stochastic factors. BMC Genomics. 2011. https:\/\/doi.org\/10.1186\/1471-2164-12-529.","DOI":"10.1186\/1471-2164-12-529"},{"key":"1798_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/humupd\/dmq052","volume":"17","author":"ECM Nelissen","year":"2011","unstructured":"Nelissen ECM, van Montfoort APA, Dumoulin JCM, Evers JLH. Epigenetics and the placenta. Hum Reprod Update. 2011;17:397\u2013417.","journal-title":"Hum Reprod Update"},{"key":"1798_CR38","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3390\/cells12081130","volume":"12","author":"C Norton","year":"2023","unstructured":"Norton C, et al. Altered epigenetic profiles in the placenta of preeclamptic and intrauterine growth restriction patients. Cells. 2023;12:1130.","journal-title":"Cells"},{"key":"1798_CR39","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1042\/CS20190070","volume":"135","author":"UM Ashraf","year":"2021","unstructured":"Ashraf UM, Hall DL, Rawls AZ, Alexander BT. Epigenetic processes during preeclampsia and effects on fetal development and chronic health. Clin Sci. 2021;135:2307\u201327.","journal-title":"Clin Sci"},{"key":"1798_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00918-1","volume":"12","author":"JH Lim","year":"2020","unstructured":"Lim JH, et al. Epigenome-wide DNA methylation profiling of preeclamptic placenta according to severe features. Clin Epigenetics. 2020;12:1\u201315.","journal-title":"Clin Epigenetics"},{"key":"1798_CR41","doi-asserted-by":"publisher","first-page":"100148","DOI":"10.1371\/journal.pone.0100148","volume":"9","author":"L Anton","year":"2014","unstructured":"Anton L, Brown AG, Bartolomei MS, Elovitz MA. Differential methylation of genes associated with cell adhesion in preeclamptic placentas. PLoS One. 2014;9:100148.","journal-title":"PLoS One"},{"key":"1798_CR42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/molehr\/gat044","volume":"19","author":"JD Blair","year":"2013","unstructured":"Blair JD, et al. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod. 2013;19:697\u2013708.","journal-title":"Mol Hum Reprod"},{"key":"1798_CR43","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/07420528.2017.1326125","volume":"34","author":"CB van den Berg","year":"2017","unstructured":"van den Berg CB, et al. Early- and late-onset preeclampsia and the DNA methylation of circadian clock and clock-controlled genes in placental and newborn tissues. Chronobiol Int. 2017;34:921.","journal-title":"Chronobiol Int"},{"key":"1798_CR44","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ejhg.2010.63","volume":"18","author":"RKC Yuen","year":"2010","unstructured":"Yuen RKC, P\u1ebdaherrera MS, Von Dadelszen P, McFadden DE, Robinson WP. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet. 2010;18:1006\u201312.","journal-title":"Eur J Hum Genet"},{"key":"1798_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.placenta.2021.05.005","volume":"110","author":"SN Almomani","year":"2021","unstructured":"Almomani SN, et al. Identification and validation of DNA methylation changes in pre-eclampsia. Placenta. 2021;110:16\u201323.","journal-title":"Placenta"},{"key":"1798_CR46","doi-asserted-by":"publisher","first-page":"107318","DOI":"10.1371\/journal.pone.0107318","volume":"9","author":"T Chu","year":"2014","unstructured":"Chu T, et al. Comprehensive analysis of preeclampsia-associated DNA methylation in the placenta. PLoS One. 2014;9:107318.","journal-title":"PLoS One"},{"key":"1798_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","volume":"602","author":"MN Moufarrej","year":"2022","unstructured":"Moufarrej MN, et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature. 2022;602:689\u201394.","journal-title":"Nature"},{"key":"1798_CR48","first-page":"397","volume":"6","author":"MN Moufarrej","year":"2023","unstructured":"Moufarrej MN, Bianchi DW, Shaw GM, Stevenson DK, Quake SR. Noninvasive prenatal testing using circulating DNA and RNA: advances, challenges, and possibilities. Annu Rev. 2023;6:397\u2013418.","journal-title":"Annu Rev"},{"key":"1798_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11906-023-01291-z","volume":"26","author":"MN Moufarrej","year":"2023","unstructured":"Moufarrej MN, Winn VD, Quake SR. Cell-free nucleic acids for early prediction of preeclampsia. Curr Hypertens Rep. 2023;26:175.","journal-title":"Curr. Hypertens. Rep."},{"key":"1798_CR50","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/15592294.2020.1816774","volume":"16","author":"G Del Vecchio","year":"2021","unstructured":"Del Vecchio G, et al. Cell-free DNA methylation and transcriptomic signature prediction of pregnancies with adverse outcomes. Epigenetics. 2021;16:642\u201361.","journal-title":"Epigenetics"},{"key":"1798_CR51","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41591-023-02510-5","volume":"29","author":"M De Borre","year":"2023","unstructured":"De Borre M, et al. Cell-free DNA methylome analysis for early preeclampsia prediction. Nat Med. 2023;29:2206\u201315.","journal-title":"Nat Med"},{"key":"1798_CR52","doi-asserted-by":"publisher","unstructured":"He W, et al. Epigenetic phenotype of plasma cell-free DNA in the prediction of early-onset preeclampsia. J Obstet Gynaecol. 2023. https:\/\/doi.org\/10.1080\/01443615.2023.2282100.","DOI":"10.1080\/01443615.2023.2282100"},{"key":"1798_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0645-x","volume":"16","author":"TJ Jensen","year":"2015","unstructured":"Jensen TJ, et al. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biol. 2015;16:1\u201311.","journal-title":"Genome Biol"},{"key":"1798_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-24348-6","volume":"12","author":"M Spinelli","year":"2022","unstructured":"Spinelli M, et al. Hypertensive disorders of pregnancy share common cfDNA methylation profiles. Sci Rep. 2022;12:1\u201310.","journal-title":"Sci Rep"},{"key":"1798_CR55","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/pd.5833","volume":"41","author":"T Chu","year":"2021","unstructured":"Chu T, Shaw P, McClain L, Simhan H, Peters D. High-resolution epigenomic liquid biopsy for noninvasive phenotyping in pregnancy. Prenat Diagn. 2021;41:61\u20139.","journal-title":"Prenat Diagn"},{"key":"1798_CR56","first-page":"687","volume":"11","author":"PA Harris","year":"2009","unstructured":"Harris PA, et al. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;11:687\u2013701.","journal-title":"J Biomed Inf"},{"key":"1798_CR57","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"P Harris","year":"2019","unstructured":"Harris P, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"key":"1798_CR58","doi-asserted-by":"crossref","unstructured":"De Koker A, van Paemel R, De Wilde B, De Preter K and Callewaert N. A versatile method for circulating cell-free DNA methylome profiling by reduced representation bisulfite sequencing. bioRxiv. 2019;663195.","DOI":"10.1101\/663195"},{"key":"1798_CR59","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/15592294.2020.1790950","volume":"16","author":"R Van Paemel","year":"2021","unstructured":"Van Paemel R, et al. Minimally invasive classification of pediatric solid tumors using reduced representation bisulfite sequencing of cell-free DNA: a proof-of-principle study. Epigenetics. 2021;16:196\u2013208.","journal-title":"Epigenetics"},{"key":"1798_CR60","unstructured":"Ewels P et al. nf-core\/methylseq: Huggy mollusc (10.5281\/zenodo.1343417). (2024)."},{"key":"1798_CR61","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571\u20132.","journal-title":"Bioinformatics"},{"key":"1798_CR62","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzber S. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"1798_CR63","doi-asserted-by":"publisher","unstructured":"Hansen KD, Langmead B, Irizarry RA. BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions. Genome Biol. 2012. https:\/\/doi.org\/10.1186\/gb-2012-13-10-r83.","DOI":"10.1186\/gb-2012-13-10-r83"},{"key":"1798_CR64","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1798_CR65","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1042\/BST20200695","volume":"49","author":"A Angeloni","year":"2021","unstructured":"Angeloni A, Bogdanovic O. Sequence determinants, function, and evolution of CpG islands. Biochem Soc Trans. 2021;49:1109\u201319.","journal-title":"Biochem Soc Trans"},{"key":"1798_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13293-020-00313-8","volume":"11","author":"A Cirkovic","year":"2020","unstructured":"Cirkovic A, et al. Systematic review supports the role of DNA methylation in the pathophysiology of preeclampsia: a call for analytical and methodological standardization. Biol Sex Differ. 2020;11:36.","journal-title":"Biol Sex Differ"},{"key":"1798_CR67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.placenta.2017.08.070","volume":"58","author":"EM Herzog","year":"2017","unstructured":"Herzog EM, et al. Early- and late-onset preeclampsia and the tissue-specific epigenome of the placenta and newborn. Placenta. 2017;58:122\u201332.","journal-title":"Placenta"},{"key":"1798_CR68","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.placenta.2017.12.013","volume":"64","author":"SL Wilson","year":"2018","unstructured":"Wilson SL, Robinson WP. Utility of DNA methylation to assess placental health. Placenta. 2018;64:S23\u20138.","journal-title":"Placenta"},{"key":"1798_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01543-7","volume":"21","author":"SN Lone","year":"2022","unstructured":"Lone SN, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022;21:1\u201322.","journal-title":"Mol Cancer"},{"key":"1798_CR70","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41586-021-04249-w","volume":"601","author":"M Rasmussen","year":"2022","unstructured":"Rasmussen M, et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature. 2022;601:422\u20137.","journal-title":"Nature"},{"key":"1798_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2020.605219","volume":"8","author":"MN Moufarrej","year":"2020","unstructured":"Moufarrej MN, Wong RJ, Shaw GM, Stevenson DK, Quake SR. Investigating pregnancy and its complications using circulating cell-free RNA in women\u2019s blood during gestation. Front Pediatr. 2020;8:1\u20138.","journal-title":"Front Pediatr"},{"key":"1798_CR72","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1373\/clinchem.2014.221648","volume":"60","author":"NBY Tsui","year":"2014","unstructured":"Tsui NBY, et al. Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin Chem. 2014;60:954.","journal-title":"Clin Chem"},{"key":"1798_CR73","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"49","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;49:672\u201383.","journal-title":"N Engl J Med"},{"key":"1798_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/EVIDoa2200161","volume":"1","author":"R Thadhani","year":"2022","unstructured":"Thadhani R, et al. Circulating angiogenic factor levels in hypertensive disorders of pregnancy. NEJM Evid. 2022;1:1\u201313.","journal-title":"NEJM Evid"},{"key":"1798_CR75","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/pd.6478","volume":"44","author":"M Aerden","year":"2023","unstructured":"Aerden M, De Borre M, Thienpont B. Cell-free DNA methylation-based preeclampsia prediction: a journey to improve maternal health. Prenat Diagn. 2023;44:418.","journal-title":"Prenat Diagn"},{"key":"1798_CR76","unstructured":"NICE. National collaboration Centre of Women\u2019s and Children\u2019s Health (UK). Hypertens. Pregnancy Manag. Hypertens. Disorders During Pregnancy London; RCOG. (2010)."},{"key":"1798_CR77","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/uog.17455","volume":"49","author":"N O\u2019Gorman","year":"2017","unstructured":"O\u2019Gorman N, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49:756\u201360.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1798_CR78","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/uog.19039","volume":"51","author":"MY Tan","year":"2018","unstructured":"Tan MY, et al. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018;51:743\u201350.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"103","key":"1798_CR79","first-page":"e1","volume":"214","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman N, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation. Am J Obstet Gynecol. 2016;214(103):e1-103.e12.","journal-title":"Am J Obstet Gynecol"},{"issue":"62","key":"1798_CR80","first-page":"e1","volume":"213","author":"D Wright","year":"2015","unstructured":"Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(62):e1-62.e10.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR81","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"LCY Poon","year":"2010","unstructured":"Poon LCY, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24:104\u201310.","journal-title":"J Hum Hypertens"},{"key":"1798_CR82","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/HYPERTENSIONAHA.108.127977","volume":"53","author":"LCY Poon","year":"2009","unstructured":"Poon LCY, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53:812\u20138.","journal-title":"Hypertension"},{"key":"1798_CR83","doi-asserted-by":"publisher","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","volume":"226","author":"P Chaemsaithong","year":"2022","unstructured":"Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071\u201397.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR84","first-page":"1","volume":"21","author":"KB De Castro Rezende","year":"2019","unstructured":"De Castro Rezende KB, et al. Performance of fetal medicine foundation software for pre-eclampsia prediction upon marker customization: cross-sectional study. J Med Internet Res. 2019;21:1\u20137.","journal-title":"J Med Internet Res"},{"key":"1798_CR85","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/uog.26183","volume":"61","author":"I Riishede","year":"2023","unstructured":"Riishede I, et al. Pre-eclampsia screening in Denmark (PRESIDE): national validation study. Ultrasound Obstet Gynecol. 2023;61:682\u201390.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1798_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000512335","volume":"48","author":"EF Zwertbroek","year":"2021","unstructured":"Zwertbroek EF, et al. Performance of the FMF first-trimester preeclampsia-screening algorithm in a high-risk population in the Netherlands. Fetal Diagn Ther. 2021;48:103\u201311.","journal-title":"Fetal Diagn Ther"},{"key":"1798_CR87","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000477934","volume":"43","author":"M Guizani","year":"2018","unstructured":"Guizani M, et al. First-trimester combined multimarker prospective study for the detection of pregnancies at a high risk of developing preeclampsia using the fetal medicine foundation-algorithm. Fetal Diagn Ther. 2018;43:266\u201373.","journal-title":"Fetal Diagn Ther"},{"key":"1798_CR88","doi-asserted-by":"publisher","first-page":"102436","DOI":"10.1016\/j.bpobgyn.2023.102436","volume":"92","author":"NMW Lee","year":"2023","unstructured":"Lee NMW, Chaemsaithong P, Poon LC. Prediction of preeclampsia in asymptomatic women. Best Pract Res Clin Obstet Gynaecol. 2023;92:102436.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1798_CR89","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","volume":"223","author":"D Wright","year":"2020","unstructured":"Wright D, Wright A, Nicolaides KH. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2020;223:12\u201323.","journal-title":"Am J Obstet Gynecol"},{"key":"1798_CR90","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijms24021503","volume":"24","author":"T Qi","year":"2023","unstructured":"Qi T, et al. Cell-free DNA fragmentomics: the novel promising biomarker. Int J Mol Sci. 2023;24:1503.","journal-title":"Int J Mol Sci"},{"key":"1798_CR91","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/diagnostics12040978","volume":"12","author":"SC Ding","year":"2022","unstructured":"Ding SC, Lo YMD. Cell-Free DNA fragmentomics in liquid biopsy. Diagnostics. 2022;12:978.","journal-title":"Diagnostics"},{"key":"1798_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-022-02710-1","volume":"23","author":"E Katsman","year":"2022","unstructured":"Katsman E, et al. Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from nanopore sequencing. Genome Biol. 2022;23:1\u201325.","journal-title":"Genome Biol"},{"key":"1798_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.202217282","volume":"15","author":"Y van der Pol","year":"2023","unstructured":"van der Pol Y, et al. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing. EMBO Mol Med. 2023;15:1\u201310.","journal-title":"EMBO Mol Med"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-024-01798-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-024-01798-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:20:26Z","timestamp":1734538826000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-024-01798-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1798"],"URL":"https:\/\/doi.org\/10.1186\/s13148-024-01798-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4887965\/v1","asserted-by":"object"}]},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical Committee of the University Hospital Ghent approved all research included in this study (2019\/0056). Written informed consent was obtained from all participants under the approval of the Ethical Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}